木蝴蝶的研究进展

作者根据近50年来的国内外研究文献,对木蝴蝶的本草考证、炮制、化学成分、质量标准、药理作用及临床的研究进行了综述。综述中发现木蝴蝶始载明代书籍,炮制方法不一,古代有“盐水炒”等,现代各省主要以“净制”为主；化学成分主要以黄酮及其苷类为主,还含有红景天苷等对羟基苯乙醇和环己醇类化合物和紫檀碱类化合物,另外还含有大量的挥发油类成分；质量标准自1995年版《中国药典》才增加了定性指标,而定量标准目前药典为空白,文献中报道多以黄芩苷为定量指标,缺乏特征性,通过对资料的整理发现,木蝴蝶苷 B这一成分目前为止还没有报道在其他药用植物中存在,对这种化学成分进行研究,确定是否可以做为木蝴蝶的特征性成分,将十分有利于木蝴蝶质量标准的提高；药理作用和临床应用与黄芩有一定的相似之处,主要以抗炎、抗诱变、抗菌、抗癌、止咳等作用为主。

Advances in the Studies of Oroxylum indicum

According to documents of recent fifty years the article summarized the herbalogical study, processing, chemical constituent, quality standard, pharmacologic action and clinical study of Oroxylum indicum. The chemical constituents mainly are flavonoids, glycoside and volatile oil. it also contains pterocarpan and rhodioside with p-hydroxyphenylethanols and cyclohexanols. Qualitative index was added in the quality standard of china pharmacopeia since 1995, but the quantitative standard is blank at the present, and the baicalin was mostly used for quantitative standard in the documents which lack of mark. Baicalein -7-O-diglucoside didn't existed in the other plants. It's mark will do good to the enhancement of quality standard. Pharmacologic action and clinical study were mainly anti-inflammatory, anti-mutagenesis, antibiosis, anticancera,and coughing.